6GV1 image
Deposition Date 2018-06-20
Release Date 2018-10-03
Last Version Date 2024-10-09
Entry Detail
PDB ID:
6GV1
Title:
Crystal structure of E.coli Multidrug/H+ antiporter MdfA in outward open conformation with bound Fab fragment
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.40 Å
R-Value Free:
0.28
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Major Facilitator Superfamily multidrug/H+ antiporter MdfA from E.coli
Gene (Uniprot):mdfA
Chain IDs:A
Chain Length:410
Number of Molecules:1
Biological Source:Escherichia coli K-12
Polymer Type:polypeptide(L)
Molecule:Fab fragment YN1074 heavy chain
Chain IDs:B (auth: H)
Chain Length:236
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Fab fragment YN1074 light chain
Chain IDs:C (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Outward open conformation of a Major Facilitator Superfamily multidrug/H+antiporter provides insights into switching mechanism.
Nat Commun 9 4005 4005 (2018)
PMID: 30275448 DOI: 10.1038/s41467-018-06306-x

Abstact

Multidrug resistance (MDR) poses a major challenge to medicine. A principle cause of MDR is through active efflux by MDR transporters situated in the bacterial membrane. Here we present the crystal structure of the major facilitator superfamily (MFS) drug/H+ antiporter MdfA from Escherichia coli in an outward open conformation. Comparison with the inward facing (drug binding) state shows that, in addition to the expected change in relative orientations of the N- and C-terminal lobes of the antiporter, the conformation of TM5 is kinked and twisted. In vitro reconstitution experiments demonstrate the importance of selected residues for transport and molecular dynamics simulations are used to gain insights into antiporter switching. With the availability of structures of alternative conformational states, we anticipate that MdfA will serve as a model system for understanding drug efflux in MFS MDR antiporters.

Legend

Protein

Chemical

Disease

Primary Citation of related structures